Dr. Scott E. Dean, MD

Dr. Dean practices at DaVita Marianna Dialysis Center in Marianna, Florida.

Dr. Dean's NPI, 1629074919, was assigned on June 22, 2005. Dr. Dean graduated from University of Illinois College of Medicine - Chicago in 1985. Dr. Dean holds Florida license ME49423.

Dr. Dean's primary practice is DaVita Marianna Dialysis Center, at 2930 Optimist Dr, Marianna, FL 32448 in Jackson County. The practice phone is (850) 482-5328.

Dr. Dean's primary practice is DaVita Marianna Dialysis Center in Marianna, Florida. Dr. Dean is also affiliated with Jackson Hospital. The medical group on file is Nephrology Associates. Dmand AI also links Dr. Dean to 3 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dean practices, 10 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Dean's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Dean is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Dean's licenses on file in 2 states: Florida and Alabama.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Dean treats.

CMS data shows 1,267 Medicare services from Dr. Dean across 12 procedure codes in 2024, for 424 Medicare patients. Medicare paid $179,182 for them.

CMS counts 424 Medicare patients who saw Dr. Dean in 2024. The largest group is 75 to 84, with 165 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 20% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dean's median patient age at 74, with 48% women.

In 2024, Dr. Dean wrote 3,263 Medicare Part D claims for 425 patients. 73% of them were for generic drugs. CMS names the drug for 2,977 of them, across 44 drugs with 11 or more claims each, at $1,010,980 in total drug cost. In 2023, CMS named 3,039 claims across 46 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dean for performance year 2024, reported individually. Dr. Dean accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Dean, published from 2016 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Carotid Stenosis, Stroke and Endarterectomy, Carotid. Dr. Dean has published most often in J Vasc Surg. Dr. Dean's most frequent co-authors are Ali F. Aburahma, MD, Zachary Thomas Aburahma and Andrew Kook Lee, MD.

CMS Open Payments shows 485 general payments to Dr. Dean from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. AstraZeneca Pharmaceuticals LP paid the most, $43,905.

Dmand AI lists 1 award for Dr. Dean, most recently CMS Stage 1 EHR in 2013.

Dr. Dean graduated from University of Illinois College of Medicine - Chicago in 1985.

Dr. Dean is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.